GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » EBIT

Synbio Tech (ROCO:1295) EBIT : NT$240.3 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Synbio Tech EBIT?

Synbio Tech's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was NT$34.4 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$240.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Synbio Tech's annualized ROC % for the quarter that ended in Dec. 2024 was 3.45%. Synbio Tech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 8.58%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Synbio Tech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 8.57%.

Synbio Tech EBIT Historical Data

The historical data trend for Synbio Tech's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synbio Tech EBIT Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
173.53 196.00 123.39 153.66 240.30

Synbio Tech Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.68 28.93 143.10 62.77 34.44

Competitive Comparison of Synbio Tech's EBIT

For the Biotechnology subindustry, Synbio Tech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synbio Tech's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synbio Tech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Synbio Tech's EV-to-EBIT falls into.


;
;

Synbio Tech EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$240.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech  (ROCO:1295) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Synbio Tech's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=92.06 * ( 1 - 34.96% )/( (1710.638 + 1765.187)/ 2 )
=59.875824/1737.9125
=3.45 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2257.825 - 139.117 - ( 414.027 - max(0, 308.447 - 716.517+414.027))
=1710.638

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2344.504 - 224.797 - ( 469.387 - max(0, 411.213 - 765.733+469.387))
=1765.187

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Synbio Tech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=137.764/( ( (1497.795 + max(139.834, 0)) + (1530.474 + max(42.573, 0)) )/ 2 )
=137.764/( ( 1637.629 + 1573.047 )/ 2 )
=137.764/1605.338
=8.58 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(102.076 + 170.392 + 24.717) - (139.117 + 0 + 18.234)
=139.834

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(106.614 + 163.491 + 19.966) - (224.797 + 0 + 22.701)
=42.573

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Synbio Tech's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=240.304/2804.692
=8.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech EBIT Related Terms

Thank you for viewing the detailed overview of Synbio Tech's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Synbio Tech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » EBIT
Comparable Companies
ROCO:6748 ROCO:6704 ROCO:4130 ROCO:4168 TPE:1762 ROCO:6846 ROCO:6892 ROCO:4724 ROCO:6564 ROCO:6872 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No.66, Beiling 6th Road, Luzhu District, Kaohsiung, TWN
Website
https://www.synbiotech.com
Synbio Tech Inc is a company specializing in the research, manufacturing, and application development of lactic acid bacteria. The company provides lactic acid bacteria screening, functional research and verification, and the introduction of advanced processes to produce safe and stable high-quality bacterial powder, OEM, ODM customized finished products, share application development technology, provide excellent service quality, and gain recognition from customers.

Synbio Tech Headlines

No Headlines